Search Results - "MAIOLINO, ÂNGELO"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Imaginological characterization of multiple myeloma lesions of the jaws through cone-beam computed tomography by Rocha, Thaiza Gonçalves, Feitosa, Édila Figuerêdo, Maiolino, Ângelo, de Magalhães Filho, Roberto José Pessoa, Guedes, Fábio Ribeiro, Torres, Sandra Regina, Visconti, Maria Augusta

    Published in Oral radiology (01-04-2020)
    “…Purpose To establish an evaluation protocol for the identification and description of the variations in multiple myeloma (MM) lesions of the jaws, by means of…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation by Maradei, Simone Cunha, Maiolino, Angelo, de Azevedo, Alexandre Mello, Colares, Marta, Bouzas, Luis Fernando, Nucci, Marcio

    Published in Blood (06-08-2009)
    “…Hepatic sinusoidal obstruction syndrome (SOS) is a serious complication in hematopoietic stem cell transplant (HSCT) recipients. To determine the impact of…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance by Garnica, Marcia, Nouér, Simone A, Pellegrino, Flávia L P C, Moreira, Beatriz M, Maiolino, Angelo, Nucci, Marcio

    Published in BMC infectious diseases (31-07-2013)
    “…The use of quinolone prophylaxis in high-risk neutropenic patients is considered standard of care but the development of resistance is a concern. Previous…”
    Get full text
    Journal Article
  16. 16
  17. 17

    CAR-T cell therapy for multiple myeloma: a practical toolkit for treatment in Brazil by Hungria, Vania, Piérola, Ana Alfonso, Filho, Jayr Schmidt, Crusoe, Edvan, Filho, Roberto José Pessoa de Magalhães, Maiolino, Angelo, Rodríguez-Otero, Paula

    Published in Hematology, Transfusion and Cell Therapy (01-04-2023)
    “…Chimeric antigen receptor T (CAR-T) cell therapy is an emerging treatment option for relapsed/refractory multiple myeloma (RRMM) that is a multi-step process…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20